Australia Breaks Ground by Allowing Psychedelic Prescriptions for Depression and PTSD

Australia has become the first country to allow psychiatrists to prescribe certain psychedelic substances, such as MDMA for PTSD and psilocybin for hard-to-treat depression. The move, which took effect on July 1, puts Australia at the forefront of research in this field. While the cultural acceptance of psychedelics is growing, medical experts caution that more research is needed on their efficacy and risks. The drugs will be expensive in Australia, costing around $10,000 per patient for treatment. However, this opportunity allows Australians to access these drugs for specific conditions outside of clinical trials and rigid protocols.